SCC13 cells were treated with two different Notch inhibitors, DAPT or R04929097 in different doses and measured by FACS analysis. 10μM Wedelolactone was used to treat SCC13 cells for 24 hours. Cells then harvested and stained with CD133 antibody for FACS analysis. Spheres or colonies were counted after 5 days drug treatment. Medium with drug were changed every three days.
Ro4929097
RO4929097 is a chemical compound manufactured by Merck Group. It is primarily used as a research tool in laboratory settings. The core function of RO4929097 is to serve as a reference standard or analytical standard for various research and development applications. No further details on the intended use or applications of this product are provided.
Lab products found in correlation
3 protocols using ro4929097
Notch and IKK Inhibitor Screening in SCC13 Cells
Inhibiting Exosomes and Notch Signaling in Cancer
HUVECs were incubated with 10 μM GW4869 (exosome inhibitor; Sigma-Aldrich, St. Louis, MO, USA) or 0.1% DMSO for 24 h. GW4869 is a cell-permeable, noncompetitive N-Smase (neutral sphingomyelinase) inhibitor. GW4869 blocks the ceramide-mediated sprouting of multivesicular bodies, thereby inhibiting the release of exosomes from multivesicular bodies. Thus, GW4869 is a commonly used as an exosome inhibitor [15 ]. For co-culture, U2OS and 143B cells were incubated with the HUVEC supernatant, HUVEC-derived exosomes (VECs-Exo) or PBS. U2OS and 143B cells were treated with 1 mM RO4929097 (γ secretase inhibitor; Sigma-Aldrich) for 24 h. The Notch receptor is cleaved by furin convertase, ADAM and γ-secretase to produce Notch intracellular domain. The Notch intracellular domain is released to the nucleus and then activates the transcription of related genes [16 (link)]. Thus, RO4929097 blocks the Notch signaling pathway by inhibiting the activity of γ secretase.
Notch Signaling Pathway Regulation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!